Cross Country Healthcare, Inc. (NASDAQ:CCRN) Shares Sold by Paradiem LLC

Paradiem LLC cut its holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 51.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 64,050 shares of the business services provider's stock after selling 67,939 shares during the quarter. Paradiem LLC owned about 0.18% of Cross Country Healthcare worth $1,450,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CCRN. SG Americas Securities LLC purchased a new stake in Cross Country Healthcare in the third quarter valued at about $453,000. Exchange Traded Concepts LLC raised its stake in shares of Cross Country Healthcare by 269.1% in the third quarter. Exchange Traded Concepts LLC now owns 49,559 shares of the business services provider's stock worth $1,229,000 after purchasing an additional 36,131 shares during the last quarter. Pinnacle Associates Ltd. raised its stake in shares of Cross Country Healthcare by 6.8% in the third quarter. Pinnacle Associates Ltd. now owns 342,699 shares of the business services provider's stock worth $8,496,000 after purchasing an additional 21,818 shares during the last quarter. Raymond James & Associates purchased a new position in shares of Cross Country Healthcare in the third quarter worth about $2,097,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Cross Country Healthcare by 305.8% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,570 shares of the business services provider's stock worth $584,000 after purchasing an additional 17,762 shares during the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.


Cross Country Healthcare Stock Performance

Cross Country Healthcare stock traded down $0.26 during midday trading on Friday, hitting $17.14. 210,368 shares of the company were exchanged, compared to its average volume of 228,958. Cross Country Healthcare, Inc. has a fifty-two week low of $15.65 and a fifty-two week high of $28.75. The business has a fifty day simple moving average of $17.92 and a two-hundred day simple moving average of $20.19. The firm has a market capitalization of $594.36 million, a PE ratio of 8.44, a price-to-earnings-growth ratio of 1.86 and a beta of 0.75.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last issued its quarterly earnings data on Wednesday, February 21st. The business services provider reported $0.29 EPS for the quarter, beating the consensus estimate of $0.27 by $0.02. Cross Country Healthcare had a return on equity of 16.93% and a net margin of 3.60%. The company had revenue of $414.04 million for the quarter, compared to analyst estimates of $404.42 million. During the same period last year, the company earned $1.09 earnings per share. Cross Country Healthcare's quarterly revenue was down 34.1% compared to the same quarter last year. As a group, equities analysts expect that Cross Country Healthcare, Inc. will post 0.92 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently issued reports on CCRN. Truist Financial reduced their price objective on Cross Country Healthcare from $22.00 to $16.00 and set a "hold" rating for the company in a research note on Thursday, February 22nd. Benchmark reduced their price objective on Cross Country Healthcare from $24.00 to $21.00 and set a "buy" rating for the company in a research note on Thursday, February 22nd. Barrington Research dropped their target price on Cross Country Healthcare from $26.00 to $24.00 and set an "outperform" rating on the stock in a report on Tuesday, February 27th. Finally, TheStreet lowered Cross Country Healthcare from a "b-" rating to a "c+" rating in a report on Friday, March 1st. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $21.67.

Read Our Latest Research Report on Cross Country Healthcare

Insider Buying and Selling at Cross Country Healthcare

In other Cross Country Healthcare news, insider Karen Mote sold 6,216 shares of the firm's stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $16.95, for a total value of $105,361.20. Following the sale, the insider now directly owns 35,101 shares of the company's stock, valued at $594,961.95. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 4.90% of the stock is owned by corporate insiders.

Cross Country Healthcare Profile

(Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Read More

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

→ He cracked the code to crypto… (From Weiss Ratings) (Ad)

Should you invest $1,000 in Cross Country Healthcare right now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: